Schedule 13G ownership disclosure

Nuvectis Pharma, Inc.

Security class unavailable

Event date: 2022-02-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001654954-22-001710
Form type
SC 13G
Filer
Mosseri Marlio Charles
CIK
CIK 1806384
Filed
Feb 15, 2022
Reporting period
Feb 08, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub